866-997-4948(US-Canada Toll Free)

Europe Recombinant Antibody Market Report 2017

Published By :

QYResearch

Published Date : Mar 2017

Category :

Pharmaceutical

No. of Pages : 117 Pages

Notes:
Sales, means the sales volume of Recombinant Antibody
Revenue, means the sales value of Recombinant Antibody

This report studies sales (consumption) of Recombinant Antibody in Europe market, especially in Germany, France, UK, Russia, Italy, Spain and Benelux, focuses on top players in these countries, with sales, price, revenue and market share for each player in these Countries, covering
A.G.Scientific
Abbott Diagnostics
Agilent Technologies
BD Biosciences
Beckman Coulter
bioMerieux
Bio-Rad Laboratories
F. Hoffmann-La Roche
Gallus Immunotech
GE Healthcare
Lonza Biologics Ltd
Merck KGaA
Meridian Life Science

Market Segment by Countries, this report splits Europe into several key Countries, with sales (consumption), revenue, market share and growth rate of Recombinant Antibody in these countries, from 2011 to 2021 (forecast), like
Germany
France
UK
Russia
Italy
Spain
Benelux

Split by product type, with sales, revenue, price, market share and growth rate of each type, can be divided into
Type I
Type II
Split by application, this report focuses on sales, market share and growth rate of Recombinant Antibody in each application, can be divided into
Application 1
Application 2

Table of Contents

Europe Recombinant Antibody Market Report 2017
1 Recombinant Antibody Overview
1.1 Product Overview and Scope of Recombinant Antibody
1.2 Classification of Recombinant Antibody
1.2.1 Type I
1.2.2 Type II
1.3 Application of Recombinant Antibody
1.3.1 Application 1
1.3.2 Application 2
1.4 Recombinant Antibody Market by Countries
1.4.1 Germany Status and Prospect (2012-2022)
1.4.2 France Status and Prospect (2012-2022)
1.4.3 UK Status and Prospect (2012-2022)
1.4.4 Russia Status and Prospect (2012-2022)
1.4.5 Italy Status and Prospect (2012-2022)
1.4.6 Spain Status and Prospect (2012-2022)
1.4.7 Benelux Status and Prospect (2012-2022)
1.5 Europe Market Size (Value and Volume) of Recombinant Antibody (2012-2022)
1.5.1 Europe Recombinant Antibody Sales and Growth Rate (2012-2022)
1.5.2 Europe Recombinant Antibody Revenue and Growth Rate (2012-2022)

2 Europe Recombinant Antibody by Manufacturers, Type and Application
2.1 Europe Recombinant Antibody Market Competition by Manufacturers
2.1.1 Europe Recombinant Antibody Sales and Market Share of Key Manufacturers (2015 and 2016)
2.1.2 Europe Recombinant Antibody Revenue and Share by Manufacturers (2015 and 2016)
2.2 Europe Recombinant Antibody (Volume and Value) by Type
2.2.1 Europe Recombinant Antibody Sales and Market Share by Type (2012-2017)
2.2.2 Europe Recombinant Antibody Revenue and Market Share by Type (2012-2017)
2.3 Europe Recombinant Antibody (Volume and Value) by Countries
2.3.1 Europe Recombinant Antibody Sales and Market Share by Countries (2012-2017)
2.3.2 Europe Recombinant Antibody Revenue and Market Share by Countries (2012-2017)
2.4 Europe Recombinant Antibody (Volume) by Application

3 Germany Recombinant Antibody (Volume, Value and Sales Price)
3.1 Germany Recombinant Antibody Sales and Value (2012-2017)
3.1.1 Germany Recombinant Antibody Sales and Growth Rate (2012-2017)
3.1.2 Germany Recombinant Antibody Revenue and Growth Rate (2012-2017)
3.1.3 Germany Recombinant Antibody Sales Price Trend (2012-2017)
3.2 Germany Recombinant Antibody Sales and Market Share by Manufacturers
3.3 Germany Recombinant Antibody Sales and Market Share by Type
3.4 Germany Recombinant Antibody Sales and Market Share by Application

4 France Recombinant Antibody (Volume, Value and Sales Price)
4.1 France Recombinant Antibody Sales and Value (2012-2017)
4.1.1 France Recombinant Antibody Sales and Growth Rate (2012-2017)
4.1.2 France Recombinant Antibody Revenue and Growth Rate (2012-2017)
4.1.4 France Recombinant Antibody Sales Price Trend (2012-2017)
4.2 France Recombinant Antibody Sales and Market Share by Manufacturers
4.3 France Recombinant Antibody Sales and Market Share by Type
4.4 France Recombinant Antibody Sales and Market Share by Application

5 UK Recombinant Antibody (Volume, Value and Sales Price)
5.1 UK Recombinant Antibody Sales and Value (2012-2017)
5.1.1 UK Recombinant Antibody Sales and Growth Rate (2012-2017)
5.1.2 UK Recombinant Antibody Revenue and Growth Rate (2012-2017)
5.1.5 UK Recombinant Antibody Sales Price Trend (2012-2017)
5.2 UK Recombinant Antibody Sales and Market Share by Manufacturers
5.3 UK Recombinant Antibody Sales and Market Share by Type
5.4 UK Recombinant Antibody Sales and Market Share by Application

6 Russia Recombinant Antibody (Volume, Value and Sales Price)
6.1 Russia Recombinant Antibody Sales and Value (2012-2017)
6.1.1 Russia Recombinant Antibody Sales and Growth Rate (2012-2017)
6.1.2 Russia Recombinant Antibody Revenue and Growth Rate (2012-2017)
6.1.6 Russia Recombinant Antibody Sales Price Trend (2012-2017)
6.2 Russia Recombinant Antibody Sales and Market Share by Manufacturers
6.3 Russia Recombinant Antibody Sales and Market Share by Type
6.4 Russia Recombinant Antibody Sales and Market Share by Application

7 Italy Recombinant Antibody (Volume, Value and Sales Price)
7.1 Italy Recombinant Antibody Sales and Value (2012-2017)
7.1.1 Italy Recombinant Antibody Sales and Growth Rate (2012-2017)
7.1.2 Italy Recombinant Antibody Revenue and Growth Rate (2012-2017)
7.1.7 Italy Recombinant Antibody Sales Price Trend (2012-2017)
7.2 Italy Recombinant Antibody Sales and Market Share by Manufacturers
7.3 Italy Recombinant Antibody Sales and Market Share by Type
7.4 Italy Recombinant Antibody Sales and Market Share by Application

8 Spain Recombinant Antibody (Volume, Value and Sales Price)
8.1 Spain Recombinant Antibody Sales and Value (2012-2017)
8.1.1 Spain Recombinant Antibody Sales and Growth Rate (2012-2017)
8.1.2 Spain Recombinant Antibody Revenue and Growth Rate (2012-2017)
8.1.8 Spain Recombinant Antibody Sales Price Trend (2012-2017)
8.2 Spain Recombinant Antibody Sales and Market Share by Manufacturers
8.3 Spain Recombinant Antibody Sales and Market Share by Type
8.4 Spain Recombinant Antibody Sales and Market Share by Application

9 Benelux Recombinant Antibody (Volume, Value and Sales Price)
9.1 Benelux Recombinant Antibody Sales and Value (2012-2017)
9.1.1 Benelux Recombinant Antibody Sales and Growth Rate (2012-2017)
9.1.2 Benelux Recombinant Antibody Revenue and Growth Rate (2012-2017)
9.1.9 Benelux Recombinant Antibody Sales Price Trend (2012-2017)
9.2 Benelux Recombinant Antibody Sales and Market Share by Manufacturers
9.3 Benelux Recombinant Antibody Sales and Market Share by Type
9.4 Benelux Recombinant Antibody Sales and Market Share by Application

10 Europe Recombinant Antibody Manufacturers Analysis
10.1 A.G.Scientific
10.1.1 Company Basic Information, Manufacturing Base and Competitors
10.1.2 Recombinant Antibody Product Type, Application and Specification
10.1.2.1 Product A
10.1.2.2 Product B
10.1.3 A.G.Scientific Recombinant Antibody Sales, Revenue, Price and Gross Margin (2012-2017)
10.1.4 Main Business/Business Overview
10.2 Abbott Diagnostics
10.2.1 Company Basic Information, Manufacturing Base and Competitors
10.2.2 Recombinant Antibody Product Type, Application and Specification
10.2.2.1 Product A
10.2.2.2 Product B
10.2.3 Abbott Diagnostics Recombinant Antibody Sales, Revenue, Price and Gross Margin (2012-2017)
10.2.4 Main Business/Business Overview
10.3 Agilent Technologies
10.3.1 Company Basic Information, Manufacturing Base and Competitors
10.3.2 Recombinant Antibody Product Type, Application and Specification
10.3.2.1 Product A
10.3.2.2 Product B
10.3.3 Agilent Technologies Recombinant Antibody Sales, Revenue, Price and Gross Margin (2012-2017)
10.3.4 Main Business/Business Overview
10.4 BD Biosciences
10.4.1 Company Basic Information, Manufacturing Base and Competitors
10.4.2 Recombinant Antibody Product Type, Application and Specification
10.4.2.1 Product A
10.4.2.2 Product B
10.4.3 BD Biosciences Recombinant Antibody Sales, Revenue, Price and Gross Margin (2012-2017)
10.4.4 Main Business/Business Overview
10.5 Beckman Coulter
10.5.1 Company Basic Information, Manufacturing Base and Competitors
10.5.2 Recombinant Antibody Product Type, Application and Specification
10.5.2.1 Product A
10.5.2.2 Product B
10.5.3 Beckman Coulter Recombinant Antibody Sales, Revenue, Price and Gross Margin (2012-2017)
10.5.4 Main Business/Business Overview
10.6 bioMerieux
10.6.1 Company Basic Information, Manufacturing Base and Competitors
10.6.2 Recombinant Antibody Product Type, Application and Specification
10.6.2.1 Product A
10.6.2.2 Product B
10.6.3 bioMerieux Recombinant Antibody Sales, Revenue, Price and Gross Margin (2012-2017)
10.6.4 Main Business/Business Overview
10.7 Bio-Rad Laboratories
10.7.1 Company Basic Information, Manufacturing Base and Competitors
10.7.2 Recombinant Antibody Product Type, Application and Specification
10.7.2.1 Product A
10.7.2.2 Product B
10.7.3 Bio-Rad Laboratories Recombinant Antibody Sales, Revenue, Price and Gross Margin (2012-2017)
10.7.4 Main Business/Business Overview
10.8 F. Hoffmann-La Roche
10.8.1 Company Basic Information, Manufacturing Base and Competitors
10.8.2 Recombinant Antibody Product Type, Application and Specification
10.8.2.1 Product A
10.8.2.2 Product B
10.8.3 F. Hoffmann-La Roche Recombinant Antibody Sales, Revenue, Price and Gross Margin (2012-2017)
10.8.4 Main Business/Business Overview
10.9 Gallus Immunotech
10.9.1 Company Basic Information, Manufacturing Base and Competitors
10.9.2 Recombinant Antibody Product Type, Application and Specification
10.9.2.1 Product A
10.9.2.2 Product B
10.9.3 Gallus Immunotech Recombinant Antibody Sales, Revenue, Price and Gross Margin (2012-2017)
10.9.4 Main Business/Business Overview
10.10 GE Healthcare
10.10.1 Company Basic Information, Manufacturing Base and Competitors
10.10.2 Recombinant Antibody Product Type, Application and Specification
10.10.2.1 Product A
10.10.2.2 Product B
10.10.3 GE Healthcare Recombinant Antibody Sales, Revenue, Price and Gross Margin (2012-2017)
10.10.4 Main Business/Business Overview
10.11 Lonza Biologics Ltd
10.12 Merck KGaA
10.13 Meridian Life Science

11 Recombinant Antibody Manufacturing Cost Analysis
11.1 Recombinant Antibody Key Raw Materials Analysis
11.1.1 Key Raw Materials
11.1.2 Price Trend of Key Raw Materials
11.1.3 Key Suppliers of Raw Materials
11.1.4 Market Concentration Rate of Raw Materials
11.2 Proportion of Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Manufacturing Process Analysis of Recombinant Antibody

12 Industrial Chain, Sourcing Strategy and Downstream Buyers
12.1 Recombinant Antibody Industrial Chain Analysis
12.2 Upstream Raw Materials Sourcing
12.3 Raw Materials Sources of Recombinant Antibody Major Manufacturers in 2015
12.4 Downstream Buyers

13 Marketing Strategy Analysis, Distributors/Traders
13.1 Marketing Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Development Trend
13.2 Market Positioning
13.2.1 Pricing Strategy
13.2.2 Brand Strategy
13.2.3 Target Client
13.3 Distributors/Traders List

14 Europe Recombinant Antibody Market Forecast (2017-2022)
14.1 Germany Recombinant Antibody Sales Forecast (2017-2022)
14.2 France Recombinant Antibody Sales Forecast (2017-2022)
14.3 UK Recombinant Antibody Sales Forecast (2017-2022)
14.4 Russia Recombinant Antibody Sales Forecast (2017-2022)
14.5 Italy Recombinant Antibody Sales Forecast (2017-2022)
14.6 Spain Recombinant Antibody Sales Forecast (2017-2022)
14.7 Benelux Recombinant Antibody Sales Forecast (2017-2022)
14.8 Europe Recombinant Antibody Sales Forecast by Type (2017-2022)
14.9 Europe Recombinant Antibody Sales Forecast by Application (2017-2022)

15 Research Findings and Conclusion

16 Appendix
Methodology
Analyst Introduction
Data Source


List of Table

List of Tables and Figures

Figure Picture of Recombinant Antibody
Table Classification of Recombinant Antibody
Figure Europe Sales Market Share of Recombinant Antibody by Type in 2015
Figure Type I Picture
Figure Type II Picture
Table Application of Recombinant Antibody
Figure Europe Sales Market Share of Recombinant Antibody by Application in 2015
Figure Application 1 Examples
Figure Application 2 Examples
Figure Germany Recombinant Antibody Revenue and Growth Rate (2012-2022)
Figure France Recombinant Antibody Revenue and Growth Rate (2012-2022)
Figure UK Recombinant Antibody Revenue and Growth Rate (2012-2022)
Figure Russia Recombinant Antibody Revenue and Growth Rate (2012-2022)
Figure Italy Recombinant Antibody Revenue and Growth Rate (2012-2022)
Figure Spain Recombinant Antibody Revenue and Growth Rate (2012-2022)
Figure Benelux Recombinant Antibody Revenue and Growth Rate (2012-2022)
Figure Europe Recombinant Antibody Sales and Growth Rate (2012-2022)
Figure Europe Recombinant Antibody Revenue and Growth Rate (2012-2022)
Table Europe Recombinant Antibody Sales of Key Manufacturers (2015 and 2016)
Table Europe Recombinant Antibody Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Recombinant Antibody Sales Share by Manufacturers
Figure 2016 Recombinant Antibody Sales Share by Manufacturers
Table Europe Recombinant Antibody Revenue by Manufacturers (2015 and 2016)
Table Europe Recombinant Antibody Revenue Share by Manufacturers (2015 and 2016)
Table 2015 Europe Recombinant Antibody Revenue Share by Manufacturers
Table 2016 Europe Recombinant Antibody Revenue Share by Manufacturers
Table Europe Recombinant Antibody Sales and Market Share by Type (2012-2017)
Table Europe Recombinant Antibody Sales Share by Type (2012-2017)
Figure Sales Market Share of Recombinant Antibody by Type (2012-2017)
Figure Europe Recombinant Antibody Sales Growth Rate by Type (2012-2017)
Table Europe Recombinant Antibody Revenue and Market Share by Type (2012-2017)
Table Europe Recombinant Antibody Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Recombinant Antibody by Type (2012-2017)
Figure Europe Recombinant Antibody Revenue Growth Rate by Type (2012-2017)
Table Europe Recombinant Antibody Sales and Market Share by Countries (2012-2017)
Table Europe Recombinant Antibody Sales Share by Countries (2012-2017)
Figure Sales Market Share of Recombinant Antibody by Countries (2012-2017)
Table Europe Recombinant Antibody Revenue and Market Share by Countries (2012-2017)
Table Europe Recombinant Antibody Revenue Share by Countries (2012-2017)
Figure Revenue Market Share of Recombinant Antibody by Countries (2012-2017)
Table Europe Recombinant Antibody Sales and Market Share by Application (2012-2017)
Table Europe Recombinant Antibody Sales Share by Application (2012-2017)
Figure Sales Market Share of Recombinant Antibody by Application (2012-2017)
Figure Germany Recombinant Antibody Sales and Growth Rate (2012-2017)
Figure Germany Recombinant Antibody Revenue and Growth Rate (2012-2017)
Figure Germany Recombinant Antibody Sales Price Trend (2012-2017)
Table Germany Recombinant Antibody Sales by Manufacturers (2015 and 2016)
Table Germany Recombinant Antibody Market Share by Manufacturers (2015 and 2016)
Table Germany Recombinant Antibody Sales by Type (2015 and 2016)
Table Germany Recombinant Antibody Market Share by Type (2015 and 2016)
Table Germany Recombinant Antibody Sales by Application (2015 and 2016)
Table Germany Recombinant Antibody Market Share by Application (2015 and 2016)
Figure France Recombinant Antibody Sales and Growth Rate (2012-2017)
Figure France Recombinant Antibody Revenue and Growth Rate (2012-2017)
Figure France Recombinant Antibody Sales Price Trend (2012-2017)
Table France Recombinant Antibody Sales by Manufacturers (2015 and 2016)
Table France Recombinant Antibody Market Share by Manufacturers (2015 and 2016)
Table France Recombinant Antibody Sales by Type (2015 and 2016)
Table France Recombinant Antibody Market Share by Type (2015 and 2016)
Table France Recombinant Antibody Sales by Application (2015 and 2016)
Table France Recombinant Antibody Market Share by Application (2015 and 2016)
Figure UK Recombinant Antibody Sales and Growth Rate (2012-2017)
Figure UK Recombinant Antibody Revenue and Growth Rate (2012-2017)
Figure UK Recombinant Antibody Sales Price Trend (2012-2017)
Table UK Recombinant Antibody Sales by Manufacturers (2015 and 2016)
Table UK Recombinant Antibody Market Share by Manufacturers (2015 and 2016)
Table UK Recombinant Antibody Sales by Type (2015 and 2016)
Table UK Recombinant Antibody Market Share by Type (2015 and 2016)
Table UK Recombinant Antibody Sales by Application (2015 and 2016)
Table UK Recombinant Antibody Market Share by Application (2015 and 2016)
Figure Russia Recombinant Antibody Sales and Growth Rate (2012-2017)
Figure Russia Recombinant Antibody Revenue and Growth Rate (2012-2017)
Figure Russia Recombinant Antibody Sales Price Trend (2012-2017)
Table Russia Recombinant Antibody Sales by Manufacturers (2015 and 2016)
Table Russia Recombinant Antibody Market Share by Manufacturers (2015 and 2016)
Table Russia Recombinant Antibody Sales by Type (2015 and 2016)
Table Russia Recombinant Antibody Market Share by Type (2015 and 2016)
Table Russia Recombinant Antibody Sales by Application (2015 and 2016)
Table Russia Recombinant Antibody Market Share by Application (2015 and 2016)
Figure Italy Recombinant Antibody Sales and Growth Rate (2012-2017)
Figure Italy Recombinant Antibody Revenue and Growth Rate (2012-2017)
Figure Italy Recombinant Antibody Sales Price Trend (2012-2017)
Table Italy Recombinant Antibody Sales by Manufacturers (2015 and 2016)
Table Italy Recombinant Antibody Market Share by Manufacturers (2015 and 2016)
Table Italy Recombinant Antibody Sales by Type (2015 and 2016)
Table Italy Recombinant Antibody Market Share by Type (2015 and 2016)
Table Italy Recombinant Antibody Sales by Application (2015 and 2016)
Table Italy Recombinant Antibody Market Share by Application (2015 and 2016)
Figure Spain Recombinant Antibody Sales and Growth Rate (2012-2017)
Figure Spain Recombinant Antibody Revenue and Growth Rate (2012-2017)
Figure Spain Recombinant Antibody Sales Price Trend (2012-2017)
Table Spain Recombinant Antibody Sales by Manufacturers (2015 and 2016)
Table Spain Recombinant Antibody Market Share by Manufacturers (2015 and 2016)
Table Spain Recombinant Antibody Sales by Type (2015 and 2016)
Table Spain Recombinant Antibody Market Share by Type (2015 and 2016)
Table Spain Recombinant Antibody Sales by Application (2015 and 2016)
Table Spain Recombinant Antibody Market Share by Application (2015 and 2016)
Figure Benelux Recombinant Antibody Sales and Growth Rate (2012-2017)
Figure Benelux Recombinant Antibody Revenue and Growth Rate (2012-2017)
Figure Benelux Recombinant Antibody Sales Price Trend (2012-2017)
Table Benelux Recombinant Antibody Sales by Manufacturers (2015 and 2016)
Table Benelux Recombinant Antibody Market Share by Manufacturers (2015 and 2016)
Table Benelux Recombinant Antibody Sales by Type (2015 and 2016)
Table Benelux Recombinant Antibody Market Share by Type (2015 and 2016)
Table Benelux Recombinant Antibody Sales by Application (2015 and 2016)
Table Benelux Recombinant Antibody Market Share by Application (2015 and 2016)
Table Recombinant Antibody Basic Information List
Table A.G.Scientific Recombinant Antibody Sales, Revenue, Price and Gross Margin (2012-2017)
Figure A.G.Scientific Recombinant Antibody Sales Market Share (2012-2017)
Table Abbott Diagnostics Basic Information List
Table Abbott Diagnostics Recombinant Antibody Sales, Revenue, Price and Gross Margin (2012-2017)
Table Abbott Diagnostics Recombinant Antibody Sales Market Share (2012-2017)
Table Agilent Technologies Basic Information List
Table Agilent Technologies Recombinant Antibody Sales, Revenue, Price and Gross Margin (2012-2017)
Table Agilent Technologies Recombinant Antibody Sales Market Share (2012-2017)
Table BD Biosciences Basic Information List
Table BD Biosciences Recombinant Antibody Sales, Revenue, Price and Gross Margin (2012-2017)
Table BD Biosciences Recombinant Antibody Sales Market Share (2012-2017)
Table Beckman Coulter Basic Information List
Table Beckman Coulter Recombinant Antibody Sales, Revenue, Price and Gross Margin (2012-2017)
Table Beckman Coulter Recombinant Antibody Sales Market Share (2012-2017)
Table bioMerieux Basic Information List
Table bioMerieux Recombinant Antibody Sales, Revenue, Price and Gross Margin (2012-2017)
Table bioMerieux Recombinant Antibody Sales Market Share (2012-2017)
Table Bio-Rad Laboratories Basic Information List
Table Bio-Rad Laboratories Recombinant Antibody Sales, Revenue, Price and Gross Margin (2012-2017)
Table Bio-Rad Laboratories Recombinant Antibody Sales Market Share (2012-2017)
Table F. Hoffmann-La Roche Basic Information List
Table F. Hoffmann-La Roche Recombinant Antibody Sales, Revenue, Price and Gross Margin (2012-2017)
Table F. Hoffmann-La Roche Recombinant Antibody Sales Market Share (2012-2017)
Table Gallus Immunotech Basic Information List
Table Gallus Immunotech Recombinant Antibody Sales, Revenue, Price and Gross Margin (2012-2017)
Table Gallus Immunotech Recombinant Antibody Sales Market Share (2012-2017)
Table GE Healthcare Basic Information List
Table GE Healthcare Recombinant Antibody Sales, Revenue, Price and Gross Margin (2012-2017)
Table GE Healthcare Recombinant Antibody Sales Market Share (2012-2017)
Table Lonza Biologics Ltd Basic Information List
Table Merck KGaA Basic Information List
Table Meridian Life Science Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Recombinant Antibody
Figure Manufacturing Process Analysis of Recombinant Antibody
Figure Recombinant Antibody Industrial Chain Analysis
Table Raw Materials Sources of Recombinant Antibody Major Manufacturers in 2015
Table Major Buyers of Recombinant Antibody
Table Distributors/Traders List
Figure Germany Recombinant Antibody Sales and Growth Rate Forecast (2017-2022)
Figure Germany Recombinant Antibody Revenue and Growth Rate Forecast (2017-2022)
Figure France Recombinant Antibody Sales and Growth Rate Forecast (2017-2022)
Figure France Recombinant Antibody Revenue and Growth Rate Forecast (2017-2022)
Figure UK Recombinant Antibody Sales and Growth Rate Forecast (2017-2022)
Figure UK Recombinant Antibody Revenue and Growth Rate Forecast (2017-2022)
Figure Russia Recombinant Antibody Sales and Growth Rate Forecast (2017-2022)
Figure Russia Recombinant Antibody Revenue and Growth Rate Forecast (2017-2022)
Figure Italy Recombinant Antibody Sales and Growth Rate Forecast (2017-2022)
Figure Italy Recombinant Antibody Revenue and Growth Rate Forecast (2017-2022)
Figure Spain Recombinant Antibody Sales and Growth Rate Forecast (2017-2022)
Figure Spain Recombinant Antibody Revenue and Growth Rate Forecast (2017-2022)
Figure Benelux Recombinant Antibody Sales and Growth Rate Forecast (2017-2022)
Figure Benelux Recombinant Antibody Revenue and Growth Rate Forecast (2017-2022)
Table Europe Recombinant Antibody Sales Forecast by Type (2017-2022)
Table Europe Recombinant Antibody Sales Forecast by Application (2017-2022)

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *